TCBPW Competitors
| TCBPWDelisted Stock | USD 0.01 0 36.84% |
TC BioPharm vs Inspira Technologies Correlation
Significant diversification
The correlation between TC BioPharm Plc and IINNW is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm Plc and IINNW in the same portfolio, assuming nothing else is changed.
Moving against TCBPW Pink Sheet
TC BioPharm Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between TC BioPharm and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of TCBPW and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of TC BioPharm Plc does not affect the price movement of the other competitor.
| -0.49 | 0.6 | 0.67 | 0.53 | PTIXW | ||
| -0.49 | -0.54 | -0.48 | -0.6 | BIAFW | ||
| 0.6 | -0.54 | 0.71 | 0.65 | AREBW | ||
| 0.67 | -0.48 | 0.71 | 0.74 | ALVOW | ||
| 0.53 | -0.6 | 0.65 | 0.74 | IINNW | ||
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between TCBPW Pink Sheet performing well and TC BioPharm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze TC BioPharm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PTIXW | 37.13 | 14.06 | 0.50 | (1.07) | 19.55 | 73.26 | 208.30 | |||
| BIAFW | 21.89 | 6.22 | 0.26 | (1.04) | 17.28 | 53.33 | 278.16 | |||
| AREBW | 10.44 | 0.43 | 0.03 | 13.39 | 12.02 | 25.79 | 69.43 | |||
| ALVOW | 12.37 | (0.61) | 0.00 | (0.37) | 0.00 | 21.43 | 78.98 | |||
| IINNW | 4.07 | (0.31) | 0.00 | 0.23 | 0.00 | 11.76 | 32.45 |
TC BioPharm Competitive Analysis
The better you understand TC BioPharm competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, TC BioPharm's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across TC BioPharm's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
TC BioPharm Competition Performance Charts
Five steps to successful analysis of TC BioPharm Competition
TC BioPharm's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by TC BioPharm Plc in relation to its competition. TC BioPharm's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of TC BioPharm in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact TC BioPharm's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to TC BioPharm Plc, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your TC BioPharm position
In addition to having TC BioPharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Theme ETFs Thematic Idea Now
Theme ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 484 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in TCBPW Pink Sheet
If you are still planning to invest in TC BioPharm Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets |